Report of the Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder 2000
Trisha Suppes(Stanford University), Alan C. Swann(The University of Texas Health Science Center at Houston), Joseph R. Calabrese(University Hospitals of Cleveland), M. Lynn Crismon(The University of Texas Southwestern Medical Center), Steven P. Shon(The University of Texas Southwestern Medical Center), Marcia G. Toprac(The University of Texas Southwestern Medical Center), Charles L. Bowden(The University of Texas at San Antonio Health Science Center), Ellen B. Dennehy(Eli Lilly (United States)), Robert M. A. Hirschfeld(Institute of Behavioral Sciences), Paul E. Keck(The University of Texas Southwestern Medical Center)
Cited by 121
Related Papers
Lifetime and 12-Month Prevalence of Bipolar Spectrum Disorder in the National Comorbidity Survey Replication
|Archives of General Psychiatry|2007|2.4k
Canadian Network for Mood and Anxiety Treatments (<scp>CANMAT</scp>) and International Society for Bipolar Disorders (<scp>ISBD</scp>) 2018 guidelines for the management of patients with bipolar disorder
|Bipolar Disorders|2018|1.8k
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation
|Psychological Medicine|2004|989
Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
|New England Journal of Medicine|2007|925
Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders
|Journal of Affective Disorders|2000|871